| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.4 |